Evidence map›Paper›PMID 34933669›Full record

ArticleJournal of neuroinflammation2021

Appearance of claudin-5

Dylan Krajewski, Debayon Paul, Shujun Ge, Evan Jellison, Joel S Pachter

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dylan KrajewskiBlood-Brain Barrier Laboratory, UConn Health, 263 Farmington Ave., Farmington, CT, 06030, USA.
Debayon PaulBlood-Brain Barrier Laboratory, UConn Health, 263 Farmington Ave., Farmington, CT, 06030, USA.
Shujun GeBlood-Brain Barrier Laboratory, UConn Health, 263 Farmington Ave., Farmington, CT, 06030, USA.
Evan JellisonDepartment of Immunology, UConn Health, 263 Farmington Ave., Farmington, CT, 06030, USA.
Joel S PachterBlood-Brain Barrier Laboratory, UConn Health, 263 Farmington Ave., Farmington, CT, 06030, USA. pachter@uchc.edu.
UConn Health · US

Funding

Regulation of CNS leukocyte extravasationR01NS099855 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI PACHTER, JOEL S · 2017 to 2021
$1.9M
NIH HHS R01 NS099855-01NINDS NIH HHS R01 NS099855
6 · The paper itself

Abstract

backgroundTight junctions (TJs) are membrane specializations characteristic of barrier-forming membranes, which function to seal the aqueous pathway between endothelial cells or epithelial cells and, thereby, obstruct intercellular solute and cellular movement. However, previous work from our laboratory found that claudin-5 (CLN-5), a TJ protein prominent at the blood-brain barrier (BBB), was also detected, ectopically, on leukocytes (CLN-5

methodsTo begin clarifying the significance of CLN-5

resultsFlow cytometric analysis revealed CLN-5

conclusionSeveral leukocyte subtypes variably acquire CLN-5 in blood before they enter the CNS, an event that may represent a novel mechanism to guide leukocytes to sites for paracellular diapedesis across the BBB.

Indexed as

AnimalsBlood-Brain BarrierCentral Nervous SystemClaudin-5Encephalomyelitis, Autoimmune, ExperimentalFemaleFlow CytometryLeukocytesMiceMice, Inbred C57BLNeuroinflammatory DiseasesTight Junction ProteinsClaudin-5Cldn5 protein, mouseTight Junction ProteinsBlood–brain barrierLeukocytesNeuroinflammationTight junctions

Identifiers

PMID34933669
PMCPMC8691042
OpenAlexW4225747844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.